Nalmefene Smoking Cessation Study

Completed · Phase 2 · Has a placebo group

Conditions studied: Smoking Cessation

In brief

To determine if nalmefene is safe and effective in smoking cessation.

Key facts

Study ID

NCT00202696

Run by

Somaxon Pharmaceuticals

People needed

76

Starts

2005-09-01

Expected to finish

2006-03-01

Last updated by the study team

2008-05-19

Who can join

Age: 25 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Smokers in good general health self reporting more than 15 cigarettes per day

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.